Sanofi has announced that its amlitelimab has shown positive results in the treatment of patients 12 years and older with atopic dermatitis (AD).

Inizio Evoke has appointed Kristin Ryan as Executive Vice President (VP), AI Transformation & Acceleration.

Skin cancer is one of the most common cancers in the US, with melanoma accounting for the majority of skin cancer deaths ...

Tickets are on sale for the 40th anniversary of the PM Awards! Book now and join us on Friday 20 March 2026 at the JW ...

Prescient acquires Uptake, with a focus on exceptional client delivery and impact in the pharmaceutical and biotech industry ...

The Novo Nordisk Foundation has allocated up to 736m euros in funding to BioInnovation Institute (BII), a leading institute ...

Dystrophic Epidermolysis Bullosa Research Association (DEBRA) Research and the University Medical Center Groningen (UMCG), ...

The Skin Health Alliance (SHA) has donated £140,000 to the British Skin Foundation (BSF) for research into skin health.

The new programme addresses the urgent unmet medical need for new therapies to tackle antibiotic-resistant infections ...

As pharma organisations invest extensively in creating engaging content, the onboarding process must not be overlooked.

Inizio, a leading global commercialisation partner for pharma and life sciences, has unveiled Inizio Ignite, a reimagined, ...

Patient engagement is not optional in pharma – it’s integral. Meaningful partnerships with patients, caregivers and advocates ...